Unknown

Dataset Information

0

The Omicron wave and the waning of COVID-19 vaccine effectiveness. Influence of vaccine booster and age on confirmed infection incidence.

ABSTRACT:

SUBMITTER: Corral-Gudino L 

PROVIDER: S-EPMC9132883 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Intraseason Waning of Influenza Vaccine Effectiveness.
| S-EPMC7182205 | biostudies-literature
Unknown Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant.
| S-EPMC8785151 | biostudies-literature
Unknown BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age.
| S-EPMC9258754 | biostudies-literature
Unknown Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.
| S-EPMC8765759 | biostudies-literature
Unknown Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents.
| S-EPMC8750715 | biostudies-literature
Unknown Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer.
| S-EPMC8595142 | biostudies-literature
Unknown A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants.
| S-EPMC9261010 | biostudies-literature
Unknown SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster.
| S-EPMC8722594 | biostudies-literature
Unknown Waning of Measured Influenza Vaccine Effectiveness Over Time: The Potential Contribution of Leaky Vaccine Effect.
| S-EPMC8422999 | biostudies-literature
Unknown Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa.
| S-EPMC8757569 | biostudies-literature